We read the article by Burkholder et al with interest.1 The study describes a potentially new biomarker, macular volume, in addition to retinal nerve fiber layer thickness to follow up patients with multiple sclerosis (MS) using optical coherence tomography (OCT).2 We offer a few comments regarding their conclusions.
Khanifar AA, Parlitsis GJ, Gauthier SA, Kiss S. Evaluating Retinal Abnormalities in Patients With Multiple Sclerosis. Arch Neurol. 2010;67(8):1035–1036. doi:10.1001/archneurol.2010.180
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.